The monograph for Etanercept (2895) is published in the Supplement 9.5 of the European Pharmacopoeia effectively July 1st, 2018.

We appreciate the publication of European Pharmacopoeia Etanercept monograph, a first of its kind of a complex Antibody. Methods like N-Glycan HPLC, Peptide Mapping, Sialic Acid Content, SEC and 1D PAGE will give good insights in quality attributes, however there is much more than these to justify Biosimilarity. 

Contact us to learn how Protagen Protein Services can support your biotherapeutical development process. Our experts are happy to discuss your request.